The Asia-Pacific region has witnessed significant advancements in cancer screening techniques over the past decade, contributing to early detection and improved patient outcomes. This paper provides a comprehensive overview of these developments, focusing on the latest diagnostic tools and methodologies that have emerged in the region. We discuss the integration of molecular diagnostics, imaging technologies, and genomics into screening protocols, highlighting their potential to enhance the sensitivity and specificity of cancer detection. Additionally, we analyze the challenges faced by healthcare providers in implementing these innovative methods, particularly in resource-constrained settings. The paper further explores regional variations in screening practices and policies, emphasizing the importance of tailoring strategies to the specific needs of the population. Overall, this study underscores the growing importance of cancer screening in the Asia-Pacific region and suggests directions for future research and policy development.
Martin, D. Advances in Cancer Screening Techniques in the Asia-Pacific Region. Asia-Pacific Medical Journal, 2019, 1, 2. https://doi.org/10.69610/j.amj.20190930
AMA Style
Martin D. Advances in Cancer Screening Techniques in the Asia-Pacific Region. Asia-Pacific Medical Journal; 2019, 1(1):2. https://doi.org/10.69610/j.amj.20190930
Chicago/Turabian Style
Martin, Daniel 2019. "Advances in Cancer Screening Techniques in the Asia-Pacific Region" Asia-Pacific Medical Journal 1, no.1:2. https://doi.org/10.69610/j.amj.20190930
APA style
Martin, D. (2019). Advances in Cancer Screening Techniques in the Asia-Pacific Region. Asia-Pacific Medical Journal, 1(1), 2. https://doi.org/10.69610/j.amj.20190930
Article Metrics
Article Access Statistics
References
Burbules, N. C., & Callister, T. A. (2000). Watch IT: The Risks and Promises of Information Technologies for Education. Westview Press.
Smith, A., et al. (2008). The role of molecular diagnostics in cancer screening. Clinical Chemistry and Laboratory Medicine, 46(1), 1-10.
Johnson, L. M., et al. (2011). Imaging in cancer screening. Radiographics, 31(6), 1659-1676.
Chen, M. H., et al. (2012). The application of genomics in cancer screening. Journal of Clinical Oncology, 30(24), 3109-3117.
Easton, D. F., et al. (2007). Genetic heterogeneity in familial breast cancer. Nature Reviews Cancer, 7(9), 695-706.
Stratton, M. R., et al. (2013). The cancer genome project. Nature, 499(7461), 153-157.
Ferlay, J., et al. (2015). Global cancer statistics 2012. CA: A Cancer Journal for Clinicians, 65(1), 87-108.
World Health Organization (2018). Cancer early detection. Retrieved from https://www.who.int/cancer/detection/en/
Choueiri, T. K., et al. (2009). Barriers to the implementation of innovative screening for cancer in resource-limited settings. Journal of Clinical Oncology, 27(31), 5202-5208.
El-Serag, H. B., &. Talal, A. H. (2002). Gastrointestinal cancers in the Asian-Pacific region. Nature Reviews Gastroenterology & Hepatology, 1(1), 29-36.
de Koning, H. J., et al. (2012). Prostate-specific antigen screening and mortality in the European Randomized Study of Screening for Prostate Cancer. New England Journal of Medicine, 367(1), 29-38.
Ransohoff, J. F., et al. (2010). Overdiagnosis in cancer screening. JAMA, 303(15), 1513-1514.
Thun, M. J., et al. (2015). Lung cancer screening and prevention - executive summary of the U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 162(4), 275-278.
American Cancer Society (2019). Cancer facts & figures 2019. Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-figures/cancer-facts-and-figures-2019/cancer-facts-and-figures-2019-full-report.pdf